Using the same classification workflow, an additional, 219 unique DLBCL patients were analyzed from a publicly available DLBCL dataset (Chapuy et al.9), in which structural variants and copy number gains in MYC and BCL2 and/or BCL6 were identified (Fig. 1B, lower panel). The gene discussed is MYC; the disease is diffuse large B-cell lymphoma.